New Drug Prevents Breast Cancer In Postmenopausal Women, UCSF Researchers Report

LOS ANGELES -- Researchers at the University of California San Francisco report that a novel hormone therapy drug reduces the risk of breast cancer in women by 70 percent.

"Our findings are very exciting because they show that it may be possible to prevent breast cancer in postmenopausal women who have no prior history of the disease," says Steven Cummings, MD, UCSF professor of medicine and epidemiology and lead author of the study.

Cummings presented his findings today (May 18) at the annual meeting of the American Society of Clinical Oncology.

UCSF researchers found that the osteoporosis prevention drug, raloxifene, drastically reduced the risk of breast cancer in postmenopausal women without indicating an increased risk of endometrial, or uterine cancer. Other drugs in raloxifene's class, including tamoxifen, have been shown to increase the risk of endometrial cancer in women.

Although tamoxifen was recently reported to reduce the risk of breast cancer in women who are at high risk of the disease by 45 percent, it also showed an increased risk of endometrial cancer. Of the 13,388 women who participated in the tamoxifen study, 33 of those who received the drug developed endometrial cancer, compared to 14 of the women assigned to placebo. Raloxifene and tamoxifen belong to a class of drugs called selective estrogen receptor modulators (SERMS), which block the actions of estrogen in some tissues, such as the breasts, and mimic estrogen in other tissues, such as the bones.

"During the clinical trials of raloxifene, we saw twice as many cases of breast cancer develop among women taking placebo compared to those taking raloxifene," Cummings says.

After an average of 33 months, 32 cases of breast cancer developed in the women who participated in the study. While 21 or .82 percent of the women who were given placebo developed breast cancer, only 11 or .21 percent of those assigned to raloxifene developed the disease. However, like tamoxif

Contact: Abby Sinnott
(415) 885-7277
University of California - San Francisco

Page: 1 2 3

Related medicine news :

1. New Chest Pain Evaluation Method Saves Lives, Prevents Costly HospitalizationFor Some Patients
2. Physicians Study Whether "Super-Aspirin" Prevents Alzheimers
3. Treatment Of Irregular Heartbeat Saves Money And Prevents Stroke In Older People
4. Drug Prevents Hearing Loss Caused By Brain Tumor Therapy
5. Compound In Meat Prevents Diabetes, Study Suggests
6. Hausman to give keynote address at Breastfeeding, Motherhood and Feminism symposium
7. Breast implant Website launched by leading plastic surgery societies
8. Breast cancer treatment reduces risk of heart disease
9. Breast reconstruction with implants after mastectomy doesnt hurt survival chances
10. Breast cancer may be uniquely sensitive to inhibitors of PI3K pathway
11. Breast MRI moderately useful for detecting breast cancer, but does not eliminate need for biopsy

Post Your Comments:

(Date:8/25/2019)... ... August 25, 2019 , ... ... is pleased to announce the addition of its first satellite office. , Located ... Suite C, off of Western Avenue in Jacksonville, North Carolina, the new office ...
(Date:8/23/2019)... Fla. (PRWEB) , ... August 23, 2019 , ... ... a strategic partnership with the West Virginia Eye Collaborative. This partnership will be ... value, and access of care, the WV Eye Collaborative and its eye physicians ...
(Date:8/21/2019)... Ala. (PRWEB) , ... August 21, 2019 , ... ... program, will open a new location in Huntsville, Ala. in early 2020. Alsana ... Hospitalization Program (PHP) and an Intensive Outpatient Program (IOP). The integrative program will ...
(Date:8/21/2019)... ... August 21, 2019 , ... ... Sunday, July 28. The Phase II expansion of Providence Point in Pittsburgh’s Scott ... well as construction of the 70-unit apartment tower, Hamilton Tower. , ...
(Date:8/19/2019)... (PRWEB) , ... August 19, 2019 , ... ... offices in Houston and San Antonio, Texas, proudly announces they have ranked #3056 ... most prominent ranking and represents a unique look at the most successful companies ...
Breaking Medicine News(10 mins):
(Date:8/21/2019)... , ... August 21, 2019 , ... ... a partnership to enhance cybersecurity workforce education and training. To commence the partnership, ... platform for cybersecurity practitioners. Businesses in the United States now have the opportunity ...
(Date:8/19/2019)... Israel (PRWEB) , ... August 19, 2019 , ... ... Israel’s leading medical centers, today announced the findings of research validating the clinical ... , The findings were published 7 August 2019 in the Journal of ...
(Date:8/17/2019)... (PRWEB) , ... August 17, 2019 , ... ... Companies—the Inc. 5000 , Foster Crown, LLC Ranks No. 2502 on the 2019 ... revealed that Foster Crown, LLC, the boutique physician recruitment firm is No. 2502 ...
Breaking Medicine Technology:
Cached News: